The most common side effects include: Loss of appetite Nausea Vomiting Diarrhea Other side effects can include: Dizziness Increased heart rate Infections Headaches Upset stomach Although rare, there are some serious side effects, including: Pancreatitis (inflammation of the pancreas) Medullary thyroid cancer Kidney injury Worsening diabetes-related retinopathy (eye disease) What are the risks
*Disclaimer: Major Players sorted in no particular order Recent Industry Developments December 2025: WHO recommended GLP-1 receptor agonists as part of comprehensive adult-obesity care, citing cardio-metabolic benefits
MicroRNAs/LncRNAs modulate MDSCs in tumor microenvironment
Moreover, due to these substitutions, semaglutide has a prolonged half-life of approximately 168 h, which is impressive given the knowledge that native GLP-1 has a half-life of 2 min, in comparison [98, 99]
Meanwhile, lower-income households, often located in regions with the highest obesity rates, face costs that place GLP-1s still firmly out of reach
Sour Apple